Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,897 | 39,029 | 19,585 | 110,368 | 18,762 |
| Marketable Securities | 113,989 | 119,138 | 131,972 | 55,660 | 45,811 |
| Receivables | 24,511 | 22,366 | 20,517 | 20,545 | 15,969 |
| Inventories | 36,264 | 29,263 | 23,662 | 19,194 | 15,364 |
| TOTAL | $219,750 | $214,257 | $199,240 | $208,906 | $98,478 |
| Non-Current Assets | |||||
| PPE Net | 67,206 | 60,632 | 56,148 | 53,513 | 49,891 |
| Investments And Advances | 19,938 | 24,431 | 24,527 | 13,474 | 0 |
| Intangibles | 25,704 | 24,164 | 22,531 | 13,084 | 11,971 |
| Other Non-Current Assets | 2,432 | 2,588 | 2,948 | 3,103 | 3,353 |
| TOTAL | $115,280 | $111,815 | $106,154 | $83,174 | $65,215 |
| Total Assets | $335,030 | $326,072 | $305,394 | $292,080 | $163,693 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,565 | 6,758 | 7,747 | 3,145 | 2,605 |
| Accrued Expenses | 25,296 | 28,311 | 23,383 | 23,035 | 16,913 |
| Other current liabilities | N/A | 276 | 602 | 869 | 1,065 |
| TOTAL | $136,453 | $140,010 | $135,223 | $129,506 | $121,587 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,426 | 1,426 | 1,426 | 1,426 | 1,008 |
| Other Non-Current Liabilities | 5,404 | 5,409 | 5,235 | 4,384 | 3,435 |
| TOTAL | $14,556 | $14,917 | $15,099 | $14,605 | $6,395 |
| Total Liabilities | $151,009 | $154,927 | $150,322 | $144,111 | $127,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,443 | 36,236 | 36,056 | 35,892 | 35,655 |
| Common Shares | 36 | 36 | 36 | 36 | 34 |
| Retained earnings | -308,885 | -310,145 | -315,947 | -312,943 | -307,906 |
| Other shareholders' equity | -28 | -80 | 8 | -31 | 5 |
| TOTAL | $184,021 | $171,145 | $155,072 | $147,969 | $35,711 |
| Total Liabilities And Equity | $335,030 | $326,072 | $305,394 | $292,080 | $163,693 |